Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
The Board of Directors approved 2023 consolidated financial statements.
2024-03-08
The Board of Directors release the prohibition on managers from participation in competition businesses.
2024-03-08
The Board of Directors approved new shares for capital increase by earnings recapitalization.
2024-03-08
The Board of Directors approved dividend distribution
2024-03-08
The Board of Directors approved the convening of the 2024 Annual Shareholders’ Meeting.
2024-03-08
Announcement on behalf of major subsidiary,Excelsior Asset Management Co., Ltd., regarding BOD Resolution on capital increase by earnings recapitalization.
2024-02-23
Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding Board Meeting Resolution on dividend distribution.
2024-02-23
Announcement to correct the company’s statements of endorsements and guarantees in November 2023.
2024-01-10
Announcement on behalf of major subsidiary, Excelsior Asset Management Co., Ltd., regarding the change of general manager.
2023-12-29
To announce the change of deputy general manager of the company.
2023-12-29
